Medical Freedom of Speech

Across the USA, COVID years pushed people to rethink how medicine, science, and government should interact.

Several states now protect medical freedom of speech, giving doctors the space to question, debate, and offer their own clinical advice without being punished for it.

With cases like Kory v. Bonta leading the way, America is building a new model of clinical independence, open scientific debate, and health sovereignty — and it’s a model New Zealand can learn from..

Note: we are talking specifically about some reforms at the state level in USA and not overall USA Federal Policy here.

The American Pivot: Protecting Doctors’ Speech

Following controversy over COVID‑19 messaging, several US states introduced laws preventing medical boards from disciplining doctors solely for expressing viewpoints that diverge from government or public‑health authorities. These reforms emerged partly in response to California’s AB 2098, which attempted to classify dissenting COVID‑19 advice as “misinformation.” AB 2098 was later repealed in 2024 after courts found it unconstitutionally vague under the Fourteenth Amendment.

Key Features of US State‑Level Reforms

• Protection of medical speech — Doctors cannot be sanctioned for viewpoint‑based COVID‑19 advice.
• Limits on government‑mandated medical messaging — Regulators cannot compel clinicians to repeat official scripts.
• Independent scientific review — States increasingly recognise real‑world evidence and independent analyses.
• Pluralistic evidence standards — Medical advice may draw from diverse sources, not only WHO guidance or pharmaceutical trial packages.
• Emergency powers with automatic sunset clauses — Emergency declarations must expire unless actively renewed.
• Emergency powers cannot be triggered by external bodies — States prevent WHO or other international organisations from initiating domestic emergency authority.
• Patient rights to alternative and natural treatments — Many states explicitly protect integrative, traditional, and natural health pathways.

These reforms collectively establish a separation of medicine and state, ensuring public health policy cannot be shaped by commercial incentives or foreign technocratic bodies.

Landmark Case: Kory v. Bonta

Kory v. Bonta is now central to the American medical‑speech landscape. The plaintiffs—Dr Pierre Kory, Dr Le Trinh Hoang, Dr Brian Tyson, Physicians for Informed Consent, and Children’s Health Defense—challenged California’s authority to discipline physicians for COVID‑19‑related speech under Business & Professions Code §2234.

The case reached the US Supreme Court (Docket 24‑932), where petitioners argued that disciplining physicians for dissenting COVID‑19 advice violates the First Amendment. The petition was ultimately denied in April 2026, but the filings and briefs show the national significance of the issue and the growing legal movement to protect medical speech.

Key Judicial Findings

• Regulators may not punish doctors for departing from “the position of the public health authorities.”

   

• Medical boards cannot reframe dissent as an “informed consent violation” simply because a doctor refuses to convey government messaging.

   

• Physician speech in the doctor‑patient relationship is protected from viewpoint discrimination under First Amendment jurisprudence.

   

How Did New Zealand Compare?

While the United States moved toward protecting medical freedom of speech, New Zealand took a very different path. During the COVID‑19 period, several doctors who questioned official guidance were investigated by the Medical Council of New Zealand, faced disciplinary hearings, and in some cases lost their practising certificates. Court action became a primary tool for enforcing compliance, and mainstream media often portrayed dissenting clinicians — including members of NZDSOS — as fringe or unsafe rather than part of a legitimate scientific debate.

At the same time, the wider science environment was under strain. Major international agencies were facing criticism for commercial influence, academic institutions were accused of gatekeeping dissent, medical journals were warning about rising scientific fraud, and some pharmaceutical companies involved had well‑documented histories of regulatory breaches. All of this created a climate where official messaging could not always be assumed to represent the safest or most balanced public‑health position.

Two Different Approaches to Governance

This produced a very different style of governance. In the US, the legal system was used to limit regulatory overreach and defend clinical independence. In New Zealand, the legal system was used to enforce regulatory authority and restrict dissent. The contrast highlights two models of health governance: one that protects open scientific discussion, and one that treats disagreement as a disciplinary matter. It raises important questions about how New Zealand wants to balance public‑health messaging with clinical independence in the future — and how far state authority can stretch before public trust begins to fracture.

While other countries made room for genuine medical exemptions, New Zealand kept the gate almost completely shut — even as cracks appeared in the global science environment. Many countries were already acknowledging vaccine injuries and offering compensation, while New Zealand continued with “safe and effective” messaging and provided few avenues for doctors to formally connect adverse reactions with the products involved. New Zealand ended up one of the least responsive communities in the world to emerging evidence.

In a future crisis, this rigidity leaves New Zealand open to information pollution — the subtle drift where risky drugs are talked up, and the dangers of experimental ones quietly fade from view.

How These Reforms Have Been Received in the United States

Professional and Public Reception

• Physicians’ groups such as Physicians for Informed Consent and Children’s Health Defense publicly support the case.
• Civil liberties advocates frame the reforms as restoring constitutional protections eroded during the pandemic.
• Medical boards express concern about reduced authority, though fraud and malpractice remain fully regulable.

Academic and Policy Commentary

The BMJ warns that doctors globally face increasing punitive scrutiny for public expression, and that freedom of speech for clinicians must be protected to maintain trust and transparency.

Why This Matters for New Zealand

New Zealand’s public‑health decision‑making relies heavily on imported frameworks from:

• WHO
• ICMRA
• SAGE
• ICH

and on industry‑produced data packages that shape Medsafe and Ministry of Health guidance. This means our “independent” advice is often downstream from global information streams that may be commercially corrupted by fraudulent or conflicted actors upstream.

If New Zealand were to continue with this restrictive model — using legal and regulatory pressure to enforce acceptance of potentially incomplete scientific information, silencing dissent, and limiting medical freedom of speech — the country faces several risks:

Risks for New Zealand

• Reduced national sovereignty over health policy
• Reduced personal sovereignty over treatment choices
• Weak protection for pluralistic clinical advice
• Insufficient independent scientific review
• Opaque conflict‑of‑interest structures
• Emergency powers vulnerable to external triggers
• Insufficient protection for indigenous & traditional health pathways
• Erosion of public trust and social cohesion
• Reduced resilience and economic stability in future crises

Overall poorer health outcomes driving higher health burden and weakening economic resilience.

What New Zealand Needs: A Legislative Blueprint

Drawing from US precedents, New Zealand could establish a modernised legislative framework protecting:

• Medical freedom of speech
• Clinical independence
• Pluralistic scientific evidence
• Independent review mechanisms
• Transparent conflict‑of‑interest rules
• Limits on emergency powers
• Patient rights to alternative and natural treatments
• Indigenous rights to traditional health pathways
• National sovereignty over health policy

Role of This Page in the Larger Project

This page forms part of a multi‑jurisdictional series (US, AUS, EU) intended to support informed policy conversation in New Zealand as new safeguards are discussed, establishing:

:

• Medical speech protections
• Clinical independence
• Separation of Medicine and State

This is the foundation for a sovereign, transparent, evidence based health governance model.